openPR Logo
Press release

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market: Size & Trends Shows a Rapid Growth by 2027

06-12-2021 10:12 AM CET | Health & Medicine

Press release from: Orion Market Reports

The Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market size is projected to reach USD 11980 million by 2027, from USD 11880 million in 2020, at a CAGR of 1% during 2021-2027.

Human Immunodeficiency Virus (HIV) -1 Therapeutics is a drug used to treat HIV. HIV is a viral infection that affects body cells that help fight infection, making the body more susceptible to other opportunistic infections. There are various drug treatment classes for the treatment of the human immunodeficiency virus.

(Get 15% Discount on Buying this Report)
A full report of Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market is available at: https://www.orionmarketreports.com/human-immunodeficiency-virus-hiv-1-therapeutics-market/57034/

Market Segments

HIV-1 Therapeutics Drug Class
• Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
• Entry and Fusion Inhibitors
• Protease Inhibitors (PIs)
• Integrase Inhibitors
• Coreceptor Antagonists

Key Players
• Gilead Sciences,Inc
• Merck and Co, Inc
• Viiv Healthcare
• AbbVie ,Inc
• Bristol- Myers Squibb Company
• Boehringer Ingelheim GmbH
• Genentech,Inc
• Cipla,Inc
• Janssen Pharmaceutica

Scope of the Report

The research study analyzes the global Human Immunodeficiency Virus (HIV)-1 Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Report

1. What was the Human Immunodeficiency Virus (HIV)-1 Therapeutics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Human Immunodeficiency Virus (HIV)-1 Therapeutics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Human Immunodeficiency Virus (HIV)-1 Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Human Immunodeficiency Virus (HIV)-1 Therapeutics market.
• The market share of the global Human Immunodeficiency Virus (HIV)-1 Therapeutics market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Human Immunodeficiency Virus (HIV)-1 Therapeutics market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Human Immunodeficiency Virus (HIV)-1 Therapeutics market.

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Immunodeficiency Virus (HIV)-1 Therapeutics Market: Size & Trends Shows a Rapid Growth by 2027 here

News-ID: 2303899 • Views:

More Releases from Orion Market Reports

Module Power Supply Market to see Huge Growth by 2031
Module Power Supply Market to see Huge Growth by 2031
The Module Power Supply Market is experiencing substantial growth, fueled by increasing demand for efficient, compact, and reliable power solutions across a wide range of industries. These power supplies, which convert electrical power to a suitable form for specific applications, are essential in sectors like telecommunications, automotive, medical devices, and consumer electronics. With technological advancements and rising energy efficiency needs, the market is expected to continue expanding, driven by innovations
Plasma Spray Guns Market to see Rapid Growth by 2031
Plasma Spray Guns Market to see Rapid Growth by 2031
The Plasma Spray Guns Market is witnessing significant growth, driven by the rising demand for surface coating and thermal spray applications across industries such as aerospace, automotive, manufacturing, and electronics. Plasma spray guns are widely used for depositing coatings on substrates to enhance their properties, including wear resistance, corrosion resistance, and thermal protection. As industries continue to focus on improving product performance and durability, the plasma spray gun market is
Plasma Surface Treatment Machine Market Will Generate Record Revenue by 2031
Plasma Surface Treatment Machine Market Will Generate Record Revenue by 2031
The Plasma Surface Treatment Machine Market is witnessing significant growth as industries increasingly adopt plasma surface treatment technology for enhancing the properties of materials. Plasma surface treatment machines are used to modify the surface characteristics of materials like metals, plastics, and ceramics, offering improvements in adhesion, corrosion resistance, and wear resistance. As the demand for advanced surface treatments rises across automotive, electronics, packaging, and manufacturing sectors, the market for plasma
Plasma Torch Market Value Projected to Expand by 2031
Plasma Torch Market Value Projected to Expand by 2031
The Plasma Torch Market is experiencing rapid growth, driven by the increasing demand for high-precision cutting and welding technologies in industries such as manufacturing, automotive, aerospace, and construction. Plasma torches are essential tools in thermal cutting applications, offering fast and accurate cuts on various materials, including metals, plastics, and composites. With advancements in plasma cutting technology and the growing need for energy-efficient solutions, the market for plasma torches continues to

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways